Technology has moved ahead in leaps and bounds over the last...

Technology has moved ahead in leaps and bounds over the last decade and I am of the view that a treatment will emerge for the Coronavirus which will send the markets into a a massive correction mode. Well before it is rolled out.
Companies such as RHT with low overheads and cloud based with a focus on a major body organ re liver will have its share price explode to new levels.
There has been minimal sells, those holding stock know the potential of this company. It is not pie in the sky, they have the products, they have the distribution, they have the contracts and when main stream medical moves focus from using blood tests/biopsy for liver analysis to the AI Ferriscan/Ferrismart it will be a different ball game.
Obesity/liver fat/and associated liver issues is a major issue in Western World health. Hepafat/Ferriscan/Ferrismart and possibly a Fibrosis technology from Resonance Health will change the scope of this company dramatically in the foreseeable future.